This document summarizes immune evasion strategies used by flaviviruses. It discusses how flaviviruses evade innate immune responses such as type I interferon responses and complement system activation. It also describes adaptive immune evasion mechanisms, including antigenic variation, antibody-dependent enhancement of infection, and inhibition of antigen presentation. The document provides diagrams illustrating key concepts and cites related studies on flavivirus immune evasion and modulation of host inflammatory responses.
Dysregulation of macrophage signal transduction by ToxoplasmaIshfaq Maqbool
A brief account of mechanism adopted by Toxoplasma gondii to evade the immune response of the host immune cells particularly macrophages by disruption of macrophage signal transduction
Parasitic infection and immunomodulation: A possible explanation for the hygi...Apollo Hospitals
Helminthic parasites have a long history of co-evolution with human beings. The incidence of helminthic infection has significantly decreased in developed countries due to better sanitary measures. However, epidemiological data suggest a corresponding increase in the incidence of autoimmune and allergic diseases in association with a reduction in helminthic infections in these societies. The immune response to helminthic infection involves both innate and adaptive processes, with a strongly polarised Th2 response being the most characteristic feature. However, there is a concomitant increase in the functional regulatory T cell responses. This might explain the paradoxical decrease in both Th2-and Th1-mediated diseases such as allergy and immune-mediated inflammatory disorders in populations with increased incidence of helminthic infection. Parasitic infection therefore appears to confer a degree of immunomodulation, and for this reason, utilising helminthic infection as a therapeutic modality for the treatment of allergic and autoimmune disease has been proposed. Improved understanding of the immunologic responses to helminth infection allows these mechanisms to be exploited, enabling manipulation of the immune response in Th1-dominant conditions such as inflammatory bowel disease and multiple sclerosis, and providing a new approach to treatment of these and other inflammatory and allergic conditions.
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
Watch the slideshow for a better understanding: https://youtu.be/frmGwCEtDnM
1. Learn how mRNA vaccines work.
2. Learn challenges in making HIV vaccines.
3. Learn about the advantage of mRNA vaccines in HIV
4. Learn about trials.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
The 'omics' revolution: How will it improve our understanding of infections a...WAidid
This slideset explains the ‘Omics’ technology and its role in the study of infections and vaccination. It is a revolution as it offers powerful tools to interrogate the animal / human immune response to vaccines and infections.
Dysregulation of macrophage signal transduction by ToxoplasmaIshfaq Maqbool
A brief account of mechanism adopted by Toxoplasma gondii to evade the immune response of the host immune cells particularly macrophages by disruption of macrophage signal transduction
Parasitic infection and immunomodulation: A possible explanation for the hygi...Apollo Hospitals
Helminthic parasites have a long history of co-evolution with human beings. The incidence of helminthic infection has significantly decreased in developed countries due to better sanitary measures. However, epidemiological data suggest a corresponding increase in the incidence of autoimmune and allergic diseases in association with a reduction in helminthic infections in these societies. The immune response to helminthic infection involves both innate and adaptive processes, with a strongly polarised Th2 response being the most characteristic feature. However, there is a concomitant increase in the functional regulatory T cell responses. This might explain the paradoxical decrease in both Th2-and Th1-mediated diseases such as allergy and immune-mediated inflammatory disorders in populations with increased incidence of helminthic infection. Parasitic infection therefore appears to confer a degree of immunomodulation, and for this reason, utilising helminthic infection as a therapeutic modality for the treatment of allergic and autoimmune disease has been proposed. Improved understanding of the immunologic responses to helminth infection allows these mechanisms to be exploited, enabling manipulation of the immune response in Th1-dominant conditions such as inflammatory bowel disease and multiple sclerosis, and providing a new approach to treatment of these and other inflammatory and allergic conditions.
mRNA rather than DNA may become the nucleotide framework for new classes of drugs and vaccines. Exciting preclinical results in prophylaxis and initial clinical data in oncology suggest that mRNA technology could be translated into improvements in lung cancer and other diseases.
Watch the slideshow for a better understanding: https://youtu.be/frmGwCEtDnM
1. Learn how mRNA vaccines work.
2. Learn challenges in making HIV vaccines.
3. Learn about the advantage of mRNA vaccines in HIV
4. Learn about trials.
Sanja Selak of Intercell AG, Vienna, Austria, presents at the ProImmune Antigen Characterization and Biomarker Discovery Summit, January 2011.
Intercell develops vaccines for the prevention and treatment of infectious diseases
The 'omics' revolution: How will it improve our understanding of infections a...WAidid
This slideset explains the ‘Omics’ technology and its role in the study of infections and vaccination. It is a revolution as it offers powerful tools to interrogate the animal / human immune response to vaccines and infections.
Proteomic Analysis of the Serum and Excretory-Secretary proteins of Trichinel...AmalDhivaharS
The nematodes of the genus Trichinella are known to cause the pressing foodborne parasitic disease Trichinellosis and these parasites are known to complete all stages of development in one host with the enteral and parenteral phases observed during infection. Proteomics, in general, pertains to the systematic identification and quantification of the totality of proteins, which is the proteome of a biological system, at a specific point in time. The available proteomic studies have paved the way to identify and characterize Trichinella stage-specific proteins reacting with infected host-specific antibodies. Yet, very few contributions provide any information about changes in the global proteomic serum profile of Trichinella-infested individuals. Studies demonstrate that various Trichinella species and their phases of the invasion produce a characteristic proteomic pattern in the serum of experimentally infected pigs. Recent investigations have found that T. spiralis infection induced strong regulatory T cell responses through parasite excretory-secretory (ES) products, characterized by an increase of some regulatory T cells and growth factors. T. spiralis has also been reported to induce the angiogenic molecule vascular endothelial cell growth factor (VEGF) during nurse cell formation towards the induction of angiogenesis for nutrient supply and waste disposal. Herein, the various analogs considered in these studies include the serum, excretory-secretory proteins, surface proteins, immune-reactive proteins from muscle larvae (ML) and so on. Intestinal cultures, striated muscle tissues, pigs, mice, beavers, contributions from patients are some of the major models exploited for this purpose. The current analysis focuses on recapitulating the recent findings driven on this area to create a common ground for further studies and to ease any difficulty in continuing the proteomic analysis of T. spiralis using in vitro and in vivo models.
Gene therapy is a technique that modifies a person's genes to treat or cure disease. Gene therapies can work by several mechanisms: Replacing a disease-causing gene with a healthy copy of the gene. Inactivating a disease-causing gene that is not functioning properly. Genetic therapies hold promise to treat many diseases, but they are still new approaches to treatment and may have risks. Potential risks could include certain types of cancer, allergic reactions, or damage to organs or tissues if an injection is involved. Recent advances have made genetic therapies much safer. Gene therapy is on course to revolutionize medical care for several conditions. The hope is that gene therapy will be a one-time curative therapeutic intervention for diseases ranging from inherited hemoglobinopathies, such as sickle cell disease and thalassemia, to acquired diseases such as HIV.
1. Immune evasion strategies of flaviviruses
Vaccine
Jing Yea,b, Bibo Zhua,b, Zhen F. Fua,b,c, Huanchun Chena,b, Shengbo Caoa,b
November 13 , 2012
a State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University,
Wuhan, Hubei 430070, PR China
b Laboratory of Animal Virology, College of Veterinary Medicine, Huazhong Agricultural
University, Wuhan, Hubei 430070, PR China
c Department of Pathology, University of Georgia, Athens, GA 30602, USA
Presented by:
Siddhesh Uday Sapre,
Roll No. 17
National Institute of Virology, INDIA
2. Genome & life-cycle of flaviviruses
• Flaviviruses: env, ss +ve- sense RNA, 10.5-11 kb genome
• Monocistronic RNA single polyprotein cleaved by
host+ viral proteases
• Host cells: Monocyte, MΦ & DCs Entry: RME
• Site of Viral RNA replication: rER & VPs(derived from
Golgi)
• Assembly: ER immature particles displaying prM
transport through trans- golgi network furin
mediated cleavage (prM to M) exocytosis
Picture credits: ViralZone.expasy.org
(2015)
3. Adapted from: Michael S Diamond, Evasion of innate and
adaptive immunity by flaviviruses, Immunology and Cell
Biology 81, 196–206 (2003)
Fig. Flavivirus infection and immune response Fig. Arboviral Infection & Host inflammatory response
Adapted from: Marieke Pingen et al., Host Inflammatory
Response to Mosquito Bites Enhances the Severity of
Arbovirus Infection, Immunity, 44, 1455-1469 (2016)
4. Simplified depiction of the putative process of flavivirus infection from
entry of the virus via the skin to clearance and/or immunopathology
Adapted from: Nicholas JC King and Alison M Kesson, Interaction of flaviviruses with cells of the vertebrate host and decoy of
the immune response Immunology and Cell Biology 81, 207–216 (2003)
5. Innate immune evasion:
1. Type I IFN response
i. Delay in PRR detection
ii. Inhibition of IFN gene transcription
iii. Suppression of IFN signalling
iv. Impairing functions of antiviral ISGs
v. sfRNAs as immunoevasins
2. Complement system evasion
3. NK cell immunity
6. Type I IFN signal pathway and evasion strategy of flaviviruses
Adapted from: Jing Yea et al. Immune evasion strategies of flaviviruses, Vaccine 31: 461-471 (2013)
7. Type I IFN signal pathway and evasion strategy of flaviviruses
Adapted from: Jing Yea et al. Immune evasion strategies of flaviviruses, Vaccine 31: 461-471 (2013)
8. Strategies used by flaviviruses to modulate complement pathway
Adapted from: Jing Yea et al. Immune evasion strategies of flaviviruses, Vaccine 31: 461-471 (2013)
10. Adaptive immune evasion:
1. Humoral immune response
i. Ag’ic variation
ii. Ab-dependent enhancement (ADE) of infection
iii. Partial maturation
2. Cellular immune response
i. Inhibition of Ag presentation
ii. Ag’ic variation
12. Strategies used by flaviviruses to evade adaptive immune responses
Adapted from: Jing Yea et al. Immune evasion strategies of flaviviruses, Vaccine 31: 461-471 (2013)
13. Unexplored areas:
1. Detailed mechanisms involved in RNA-based strategies for immune
evasion
2. Quality of adaptive immune response affected by modulation of
innate immune responses
3. If flaviviruses interfere with the expression of various molecules like
integrins, chemokines and relative receptors involved in rolling and
migration of various immune cells
14. Related studies
1. Ali Zohaib et al. The Role of Ubiquitination in Regulation of Innate Immune Signaling,
Curr. Issues Mol. Biol. 18: 1-10 (2016)
2. RongJiang et al. Roles of TLR3 and RIG-I in Mediating the Inflammatory Response in
Mouse Microglia following Japanese Encephalitis Virus Infection, Journal of Immunology
Research, 2014: 1-11 (2014)
3. Rui Jin et al. Japanese Encephalitis Virus Activates Autophagy as a Viral Immune Evasion
Strategy, PLoS One, 8: 1-11 (2013)
4. Mehul S. Suthar et al. Innate Immune Sensing of Flaviviruses, PLoS Pathogens 9: 1-4
(2013)
5. Daniel Ruzek et al. Breakdown of the Blood-Brain Barrier during Tick-Borne Encephalitis
in Mice Is Not Dependent on CD8+ T-Cells, 6 (5): 1-9 (2011)
15. References
1. Michael S Diamond, Evasion of innate and adaptive immunity by flaviviruses, Nature
Immunology and Cell Biology 81: 196–206 (2003)
2. Nicholas JC King and Alison M Kesson, Interaction of flaviviruses with cells of the
vertebrate host and decoy of the immune response Nature Immunology and Cell
Biology 81: 207–216 (2003)
3. John S Mackenzie, Duane J Gubler & Lyle R Petersen Emerging flaviviruses: the spread
and resurgence of Japanese encephalitis, West Nile and dengue viruses Nature
Medicine 10: 98-109 (2004)
4. Nicholas JC King et al. Immunopathology of flavivirus infections, Nature Immunology
and Cell Biology 85: 33–42 (2007)
5. Katherine R. Spindler et al. Viral disruption of the blood-brain barrier, Trends
Microbiol. 20 (6): 282-290 (2012)